Table 2.

Liver function tests in patients with renal failure at start and end of intravenous voriconazole therapy

	ASAT (IU/l)a		γ-GT (IU/l)b		Total bilirubin (mg/dl)c
	start	end	start	end	start	end
patient no. 1	104	24	119	264	2.32	1.39
patient no. 2	100	26	93	71	0.83	0.32
patient no. 3	54	25	288	443	4.93	7.27
patient no. 4	30	22	238	216	3.29	1.34

^anorm < 37 IU/l, ^bnorm 10–66 IU/L, ^cnorm 0.1–1.2 mg/dl